head and neck cancer

Home Tag

Dra. Irene Braña

Vall d’Hebron participates in a study that supports the use of pembrolizumab in head and neck squamous cell carcinoma with new data confirming its long-term efficacy

The five-year follow up data from patients in the KEYNOTE-048 trial have been reported, with the participation of Dr. Irene…